Distillery Therapeutics

<div class="articleContainer"><div class="articleWrapper"><div class="articleContent"><h1 class="text title">miR-17-92 gene therapy for ALS associated with SOD1 mutations</h1><div class="byline">Claire Quang</div><div class="date"></div></div></div></div>

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

Academia Sinica

INDICATION: Amyotrophic lateral sclerosis (ALS)......

Amyotrophic lateral sclerosis (ALS)

MicroRNA-17-92 (miR-17-92)

miR-17-92 gene therapy for ALS associated with SOD1 mutations

Featured Analysis

Articles by Category

Current Editions

Data Graphics

Distillery: Disruptive Innovation

Distillery

Hot Topics

Podcasts & Webcasts

Special Reports & Presentations

White Papers

Analysis

BCIQ

Company Profiles

Product Profiles

Target Profiles

Financial Dashboards

BCIQ Data

All Events

Bio€quity Europe

BioCentury Grand Rounds 2024

BioCentury Grand Rounds

The BioCentury-BayHelix China Healthcare Summit

BioCentury-BayHelix China Healthcare Summit

The BioCentury Show

Webinars - Upcoming & On-Demand

Events

My Workspace

Company Overview

Management

Analysts & Research Team

Scientific Advisory Board

About BioCentury

Contact Us

Forgot Password

Request a Trial

Request a Subscription

Advertising - Sponsorship Inquiry

Media Kit

Request BioCentury's BCIQ Brochure

Customer Resource Center

Career Opportunities

Contact

Home